DEFA14A ·Filed Apr 24, 2026

BBIO

BridgeBio Pharma, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001140361-26-016724
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the company's next 10-Q or 10-K filing for any updates on corporate governance or shareholder proposals.

DirectionNeutral
Confidencelow
Horizonweeks
Final — all horizons settled through T+60d
BBIO ▲ +10.92% at T+60d
NEUTRAL call ✓ call won +10.92% · α vs SPY +6.15% · entry $74.52 → $82.66
Entry anchored
Apr 24, 03:59 PM ET
via exchange tick
T+1d
-6.45%
call -6.45% · α -5.97%
$69.71
settled 5mo ago
T+5d
-7.42%
call -7.42% · α -7.82%
$68.99
settled 5mo ago
T+20d
-9.11%
call -9.11% · α -14.07%
$67.73
settled 4mo ago
T+60d
+10.92%
call +10.92% · α +6.15%
$82.66
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable

Key Facts

  • Filing type is DEFA14A, indicating a definitive proxy statement.
  • No substantive document content was provided to analyze the vote details, management position, or activist demands.
  • Filing is routine for public companies and typically involves standard corporate governance matters.

Financial Impact

No financial impact data available

Risk Factors

  • Inability to assess potential shareholder activism or governance risks due to missing document content.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-016724
Document: 0001140361-26-016724-index-headers.html0001140361-26-016724
Document: 0001140361-26-016724-index.html0001140361-26-016724
Document: 0001140361-26-016724.txt0001140361-26-016724
26 reports for BBIO
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +26.76%May 11, 2026
Filters
Rows
Reports for BBIO — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$76.59 $65.97▼ −13.87%▼ −13.68%$67.47 (−11.90%)
Aug 26, 2026
5w ago
Press Release
BULLISH ★ 7/10
$79.37 $66.28▼ −16.49%▼ −16.72%$67.47 (−14.99%)
Aug 22, 2026
5w ago
Institutional Cluster
MIXED ★ 6/10
$81.07 $69.23▼ −14.60%▼ −15.92%$67.47 (−16.77%)
Aug 17, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$79.89 $72.38▼ −9.40%▼ −7.87%$67.47 (−15.54%)
Aug 13, 2026
7w ago
Press Release
BEARISH ★ 5/10
$79.86 $72.38▲ +9.37%▲ +7.38%$67.47 (+15.51%)
Aug 10, 2026
7w ago
8-K
NEUTRAL ★ 5/10
$84.67 $76.08▼ −10.15%▼ −9.09%$67.47 (−20.31%)
Aug 10, 2026
7w ago
Press Release
MIXED ★ 6/10
$84.67 $76.08▼ −10.15%▼ −9.09%$67.47 (−20.31%)
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$83.08 $84.67▲ +1.91%▼ −1.27%$67.47 (−18.78%)
Jun 28, 2026
13w ago
Press Release
BULLISH ★ 8/10
$72.01 $84.02▲ +16.68%▲ +16.96%$67.47 (−6.30%)
Jun 24, 2026
14w ago
144
NEUTRAL ★ 2/10
$69.69 $82.93▲ +19.00%▲ +18.47%$67.47 (−3.18%)
Showing 10 of 26

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access